Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
357 GBX | -3.51% | -8.46% | +1.28% |
11/06 | MaxCyte CEO Maher Masoud buys 100,000 shares | AN |
11/06 | Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.28% | 49Cr | |
+7.23% | 22TCr | |
+11.31% | 19TCr | |
+28.94% | 15TCr | |
+32.00% | 11TCr | |
-0.46% | 6.28TCr | |
+16.09% | 5.33TCr | |
+0.94% | 4.88TCr | |
-2.97% | 3.94TCr | |
+1.23% | 3.57TCr |
- Stock Market
- Equities
- MXCT Stock
- News MaxCyte, Inc.
- MaxCyte Signs License Deal With Legend Biotech for Cell Therapy Program